Fady Ibrahim, Cpa
About Fady Ibrahim, Cpa
Fady Ibrahim, CPA, is the Executive Director R&D FP&A & Controller at Bristol Myers Squibb with over 15 years of experience in accounting and finance, particularly in the pharmaceutical sector.
Executive Director R&D FP&A & Controller
Fady Ibrahim currently holds the position of Executive Director R&D FP&A & Controller at Bristol Myers Squibb in Princeton, New Jersey. He transitioned to this role in July 2023. In this capacity, Fady is responsible for overseeing financial planning and analysis within the research and development sector, providing strategic financial guidance, and ensuring robust financial controls. His extensive background in finance and accounting, particularly within the pharmaceutical industry, positions him well to drive performance and support the company's research initiatives.
Senior Director US Immunology Finance
Before becoming Executive Director R&D FP&A & Controller, Fady Ibrahim served as Senior Director, US Immunology Finance at Bristol Myers Squibb from 2022 to 2023. During his 11-month tenure in this role, Fady was instrumental in managing financial operations and providing financial insights for the US Immunology division. His work involved detailed financial planning, resource allocation, and strategic support to optimize financial outcomes for the immunology product line.
Program Lead, Global Commercial Smart Budgeting Capability Implementation
In 2022, Fady Ibrahim led the implementation of the Global Commercial Smart Budgeting Capability at Bristol Myers Squibb. Over a period of 7 months, he spearheaded this initiative, which involved the deployment of advanced budgeting tools and methodologies designed to enhance global commercial financial planning and accuracy. His leadership in this project demonstrated his ability to manage complex financial transformations and improve budgetary controls and efficiencies within the organization.
Director and Associate Director, US Commercial FP&A
Fady Ibrahim has held multiple pivotal roles in US Commercial FP&A at Bristol Myers Squibb. He served as Director from 2020 to 2022 and as Associate Director from 2017 to 2020. In these positions, he was responsible for the financial planning and analysis functions within the US commercial division, providing critical financial oversight and strategy to support business operations. His work included financial forecasting, budgeting, and performance analysis which contributed to the overall financial health and strategic direction of the company’s US commercial operations.
Senior Manager Audit at KPMG
Before joining Bristol Myers Squibb, Fady Ibrahim spent 9 years at KPMG as a Senior Manager in Audit from 2006 to 2015. Based in Short Hills, NJ, he was responsible for overseeing audit engagements, managing audit teams, and ensuring compliance with regulatory standards. His role required a deep understanding of financial reporting and auditing standards, which laid a strong foundation for his subsequent roles in finance and accounting.
Education and Accounting Expertise
Fady Ibrahim holds a Bachelor of Science (BS) in Accounting from Monmouth University. His academic background in accounting has been pivotal to his career, providing him with the foundational knowledge and technical skills necessary for his roles. With over 15 years of experience in accounting and finance across various industries, Fady has developed a keen expertise in financial management, strategic planning, and audit. His recent focus has been within the pharmaceutical sector, emphasizing his capability to adapt and excel in industry-specific financial roles.